← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 12, 2018Last known activity
Aug 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 5 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT06538883CollaboratorN/AAug 1, 2024
- NCT06462313CollaboratorN/AJul 22, 2024
- NCT05901584CollaboratorPhase 2Jan 1, 2023
- NCT05631782Lead sponsorEarly Phase 1Nov 10, 2020
- NCT05631782Reponsible party - principal investigatorEarly Phase 1Nov 10, 2020
- NCT03571126CollaboratorPhase 4Oct 12, 2018
Details
- Last known activity
- Aug 1, 2024